Published in Eur J Neurol on July 01, 1999
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ (2005) 3.83
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review. Open Med (2009) 1.62
Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 1.59
Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology (2011) 1.42
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.14
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling. Discov Med (2012) 0.86
Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors. PLoS One (2015) 0.84
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease. Dialogues Clin Neurosci (2000) 0.79
Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine. AAPS J (2010) 0.78
Rivastigmine in Alzheimer's disease: Cognitive function and quality of life. Ther Clin Risk Manag (2007) 0.77
Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine. J Neural Transm (Vienna) (2009) 0.77
Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease. Front Aging Neurosci (2014) 0.75
Rivastigmine in the treatment of patients with Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.75
A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res (1990) 8.52
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
A model for the separation of large DNA molecules by crossed field gel electrophoresis. Nucleic Acids Res (1987) 3.58
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA (2001) 2.38
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. J Exp Med (1985) 2.15
Creutzfeldt-Jakob disease : report of 10 cases from North India. Neurol India (2001) 2.02
Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet (1993) 2.00
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol (2000) 1.98
Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol (1994) 1.68
Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66
The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. J Biol Chem (2001) 1.58
Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device. Arch Ophthalmol (1992) 1.56
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49
Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet (1987) 1.47
An unusual complication of an inferior dental nerve block: a case report. Br Dent J (2009) 1.42
Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol (1994) 1.39
A simple technique to control the hair and enhance draping for major head and neck surgery. Br J Oral Maxillofac Surg (2011) 1.38
Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol (1992) 1.33
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem (1998) 1.33
Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol (1988) 1.33
Isolation of cDNA clones using yeast artificial chromosome probes. Nucleic Acids Res (1990) 1.28
Peripapillary angiomatosis associated with cat-scratch neuroretinitis. Arch Ophthalmol (1992) 1.27
Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol Pharmacol (1994) 1.27
Nephrotic syndrome in indian children. Arch Dis Child (1975) 1.25
Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med (1983) 1.23
Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant (2004) 1.23
Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet (1992) 1.22
Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol (1997) 1.21
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol (1987) 1.19
Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord (1997) 1.18
Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant (2004) 1.17
"Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol Pharmacol (1997) 1.17
46-53 kilodalton glycoprotein from the surface of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1989) 1.15
Age changes in the occlusal pattern of deciduous dentition. J Dent Res (1973) 1.13
Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines. J Virol (1981) 1.12
Needle breakage following inferior alveolar nerve block: implications and management. Br Dent J (2007) 1.11
Neuronal nicotinic receptor subtypes. Ann N Y Acad Sci (1995) 1.11
Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant (2007) 1.09
Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol (2001) 1.08
Diagnostic potential of IS6110, 38kDa, 65kDa and 85B sequence-based polymerase chain reaction in the diagnosis of Mycobacterium tuberculosis in clinical samples. Indian J Med Microbiol (2007) 1.08
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease. Life Sci (1996) 1.06
An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol (2000) 1.03
Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant (2007) 1.03
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations. Mov Disord (2013) 1.03
Identification and characterisation of proteins associated with the rhoptry organelles of Plasmodium falciparum merozoites. Parasitol Res (1987) 1.02
Targeted integration of neomycin into yeast artificial chromosomes (YACs) for transfection into mammalian cells. Nucleic Acids Res (1992) 1.01
Influence of the cannulated vitrectomy system on the occurrence of iatrogenic sclerotomy retinal tears. Retina (1997) 1.01
Human immunodeficiency virus replication in human brain cells. Brief report. Arch Virol (1988) 1.01
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Orbital infarction syndrome after surgery for intracranial aneurysms. Ophthalmology (1995) 0.99
Water-soluble nicotinic acetylcholine receptor formed by alpha7 subunit extracellular domains. J Biol Chem (1998) 0.99
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology (2000) 0.99
Identification of CpG islands in a physical map encompassing the Friedreich's ataxia locus. Genomics (1991) 0.99
Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep. Pediatr Res (1980) 0.98
Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression. Arch Neurol (2001) 0.96
N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology (1998) 0.95
Urinary 4-pyridoxic acid, plasma pyridoxal phosphate, and erythrocyte aminotransferase levels in oral contraceptive users receiving controlled intakes of vitamin B6. Am J Clin Nutr (1975) 0.94
Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics (1992) 0.94
Generation of ordered phage sublibraries of YAC clones: construction of a 400-kb phage contig in the human dystrophin gene. Genomics (1993) 0.94
A prospective study of the use of fine-needle aspiration cytology and core biopsy in the diagnosis of breast cancer. Breast J (2003) 0.93
Multiple synchronous and metachronous neoplasms of the parotid gland: the Chichester experience. Br J Oral Maxillofac Surg (2005) 0.93
Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease. Eur J Neurol (2012) 0.93
An audit of 405 temporomandibular joint arthrocentesis with intra-articular morphine infusion. Br J Oral Maxillofac Surg (2003) 0.93
Communicating oesophageal duplication: a report of two cases. Gut (1988) 0.92
N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer (1993) 0.92
Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat. Hepatology (1999) 0.92
Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons. Mol Cell Neurosci (2008) 0.92
Intravascular papillary endothelial hyperplasia (Masson's tumour) of the oral mucosa. Br J Oral Maxillofac Surg (2010) 0.91
Retroperitoneal lymphangioma presenting as an inguinal hernia. Indian Pediatr (1994) 0.91
Recent translocation of variable and diversity segments of the human immunoglobulin heavy chain from chromosome 14 to chromosomes 15 and 16. Genomics (1994) 0.91
Effects on regional cerebral blood flow of transcendental meditation. Physiol Behav (1996) 0.90
Before you reach for the bleach... Br Dent J (2011) 0.90
Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC-qTOF-MS: evidence that PA-1 enhances the oral bioavailability of etoposide in mice. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.90
Linear growth patterns in prepubertal children following liver transplantation. Am J Transplant (2009) 0.90
Rifabutine inhibits HTLV-III. Lancet (1986) 0.90
Glomerular filtration rate following pediatric liver transplantation--the SPLIT experience. Am J Transplant (2010) 0.90
The contemporary management of chyle leak following cervical thoracic duct damage. Br J Oral Maxillofac Surg (2011) 0.89
Trismus: an unconventional approach to treatment. Br J Oral Maxillofac Surg (2005) 0.89
Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) to human chromosome 20q13.2-q13.3. Genomics (1994) 0.89
Macular pseudoholes. Clinical features and accuracy of diagnosis. Ophthalmology (1992) 0.89
Day case emergency laparoscopic appendectomy. Surg Endosc (2007) 0.88
Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res (1993) 0.88
Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications. Int J Geriatr Psychiatry (2000) 0.88
Multifocal cystic bone tuberculosis with lupus vulgaris and lymphadenitis. Indian Pediatr (1997) 0.88
Intracellular neuronal calcium sensor (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurones. J Neurochem (2001) 0.87
Effect of oral habits on the occlusion in preschool children. ASDC J Dent Child (1973) 0.87
Dementia with lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry (2000) 0.87
Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1991) 0.87
Clozapine: the commitment to patient safety. J Clin Psychiatry (1999) 0.87
Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett (1990) 0.87
How many types of erythroleukaemia are induced by retroviruses in mice? Nature (1980) 0.87
Intravitreal drug administration with depot devices. Curr Opin Ophthalmol (1994) 0.87
Simplified technique for suturing dislocated posterior chamber intraocular lens to the ciliary sulcus. Arch Ophthalmol (1990) 0.86